Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
Category: Access campaign
MSF: Game-changing HIV prevention medicine must be available for $40 per year, everywhere
Read More
MSF wants to buy groundbreaking HIV prevention drug. Why won’t Gilead sell?
Read More
Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions
Read More
Central African Republic: Living with Diabetes in Carnot
Read More
Bangladesh: MSF launches a large hepatitis C “test and treat” campaign amid critical lack of treatment options
Read More
Migrating while managing diabetes: why access to insulin in pens must be available to everyone
Read More
MSF and global TB activists take stage at annual TB conference
Read More
Ahead of World Diabetes Day, pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 per pen
Read More
India: Addressing Healthcare Challenges for people living with HIV in Patna
Read More
Activists at AIDS2024 demand: Break Gilead’s Lenacapavir monopoly
Read More